Loading clinical trials...
Loading clinical trials...
A Phase I, Randomized, Double-Blind, Placebo-Contralled, Single Asending Dose / Multiple Ascending Dose Study of CS0159 to to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics, and Effect Food in Healthy Subject
Conditions
Interventions
CS0159
Locations
1
United States
Labcorp Clinical Research Unit, Inc.
Daytona Beach, Florida, United States
Start Date
October 26, 2021
Primary Completion Date
September 16, 2022
Completion Date
October 12, 2022
Last Updated
October 18, 2022
NCT06026865
NCT01161992
NCT06686810
NCT06037577
NCT03766035
NCT02177136
Lead Sponsor
Cascade Pharmaceuticals, Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions